How lean biotechs can maintain sponsor oversight

Oversight capacity is not the same as headcount

A small sponsor does not need to reproduce every CRO function internally. It does need enough qualified capacity to understand important activity, evaluate risk, make sponsor decisions, and verify follow-through.

Build the minimum effective system

• Name accountable sponsor decision-makers
• Define CRO and vendor interfaces
• Establish a risk-based governance cadence
• Maintain one reliable set of risks, issues, actions, and decisions
• Set escalation thresholds before a crisis
• Review evidence around participant protection, data reliability, and major milestones

Add capacity where judgment is needed

Embedded support can be useful when a sponsor needs senior clinical operations or medical perspective but does not yet need a permanent full-time structure. The scope should be explicit, integrated with existing providers, and designed for continuity.

Avoid governance overload

Lean teams are especially vulnerable to duplicate trackers and low-value meetings. Use a small number of artifacts that produce visibility and decisions. Expand the cadence temporarily when enrollment, safety signals, vendor recovery, database milestones, or inspection risk justify it.